The long QT syndrome: Ion channel diseases of the heart

Mayo Clinic Proceedings

Volumn 73, Issue 3, 1998, Pages 250-269

  Ackerman, Michael J ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CISAPRIDE; NEUROLEPTIC AGENT; ORGANOPHOSPHATE INSECTICIDE;

AUTOSOMAL DOMINANT INHERITANCE; CARDIOGRAPHY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENOTYPE; HEART DISEASE; HEART MUSCLE POTENTIAL; HUMAN; LONG QT SYNDROME; PHENOTYPE; POTASSIUM CURRENT; REVIEW; SUDDEN DEATH; SYNCOPE; TORSADE DES POINTES;

EID: 0031916794     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.3.250     Document Type: Review

References (106)

1. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart diseases: the Framingham Study. Am Heart J 1987;113:799-804
2. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60:801806
3. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death. Am Heart J 1957;54:59-68
4. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'eta' pediatrica. II. Access! sincopali per fibrillazione ventricolare parossistica. Clin Pediatr (Bologna) 1963;45:656-683
5. Ward OC. A new familial cardiac syndrome in children. J Irish Med Assoc 1964:54:103-106
6. Ackerman MJ, Clapham DE. Ion channels-basic science and clinical disease. N EnglJ Med 1997;336:1575-1586
7. Janeira LF. Torsades de pointes and long QT syndromes. Am Fam Physician 1995:52:1447-1453
8. Roden DM. Current status of class III antiarrhythmic drug therapy. Am J Cardiol 1993;72:44B-49B
9. Suessbrich H, Schonherr R, Heinemann SH, Attali B, Lang F, Busch AE. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 1997;120:968-974
10. Roy M, Dumaine R, Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 1996:94:817-823
11. Lewin MB, Bryant RM, Fenrich AL, Grifka RG. Cisapride-induced long QT interval. J Pediatr 1996;128:279-281
12. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol 1996:28:1836-1848
13. Alderton HR. Tricyclic medication in children and the QT interval: case report and discussion. Can J Psychiatry 1995;40:325329
14. Thomas SH. Drugs, QT interval abnormalities and ventricular arrhythmias. Adverse Drug React Toxicol Rev 1994:13:77-102
15. Koh KK, Rim MS, Yoon J, Kim SS. Torsade de pointes induced by terfenadine in a patient with long QT syndrome. J Electrocardiol 1994:27:343-346
16. Brandriss MV, Richardson WS, Barold SS. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Clin Infect Dis 1994:18:995998
17. Zimmerman M, Duruz H, Guinand 0, Broccard 0, Levy P, Lacatis D, et al. Torsades de pointes after treatment with terfenadine and ketoconazole. Eur Heart J 1992:13:1002-1003
18. Chvilicek JP, Hurlbert BJ, Hill GE. Diuretic-induced hypokalaemia inducing torsades de pointes. Can J Anaesth 1995:42:11371139
19. Lazzara R. Mechanisms and management of congenital and acquired long QT syndromes. Arch Mal Coeur Vaiss 1996;89(Special Issue 1):51-55
20. Roden DM. Torsade de pointes. Clin Cardiol 1993;16:683-686
21. Yokoyama A, Ishii H, Takagi T, Hori S, Matsushita S, Onishi S, et al. Prolonged QT interval in alcoholic autonomie nervous dysfunction. Alcohol Clin Exp Res 1992;16:1090-1092
22. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, et al. A novel mutation in thé potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997;15:186-189
23. Splawski I, Timothy KW, Vincent G M, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997;336:1562-1567
24. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress lKs function. Nat Genet 1997; 17:338-340
25. Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997;17:267-268
26. Keating MT. The long QT syndrome: a review of recent molecular genetic and physiologic discoveries. Medicine 1996;75:l-5
27. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-370
28. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992;327:846-852
29. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993;88:782-784
30. Dessertenne F. La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur 1966;59:263-272
31. Moss AJ, Robinson JL. Long QT syndrome. Heart Dis Stroke 1992:1:309-314
32. Moss AJ, Robinson JL. Clinical aspects of the idiopathic long QT syndrome. Ann N Y Acad Sci 1992;644:103-111
33. Garson AJ Jr, Dick Ml II, Fournier A, Gillette PC, Hamilton R, Kugler JD, et al. The long QT syndrome in children: an international study of 287 patients. Circulation 1993;87:1866-1872
34. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144
35. Ackerman MJ, Porter CJ. Identification of a family with inherited long QT syndrome following a pédiatrie near drowning. Pediatrics 1998:101:306-308
36. Ackerman MJ, Clapham DE. Normal cardiac electrophysiology: understanding the action potential in the human heart. In: Chien K, editor. Molecular Basis of Heart Disease: A Companion to Braunwald's Heart Disease [in press]
37. Katz AM. Cardiac ion channels. N Engl J Med 1993:328:12441251
38. Goldstein SA. A structural vignette common to voltage sensors and conduction pores: canaliculi. Neuron 1996;16:717-722
39. Lawrence JH, Tomaselli GF, Marban E. Ion channels: structure and function. Heart Dis Stroke 1993;2:75-80
40. Roden DM, George AL Jr, Bennett PB. Recent advances in understanding the molecular mechanisms of the long QT syndrome. J Cardiovasc Electrophysiol 1995:6:1023-1031
41. Coraboeuf E, Nargeot J. Electrophysiology of human cardiac cells. Cardiovasc Res 1993:27:1713-1725
42. Shih H-T. Anatomy of the action potential in the heart. Tex Heart Inst J 1994:21:30-41
43. Ten Eick RE, Whalley DW, Rasmussen HH. Connections: heart disease, cellular electrophysiology, and ion channels. FASEB J 1992:6:2568-2580
44. Vincent GM. Genetics and molecular biology of the inherited long QT syndrome. Ann Med 1994;26:419-425
45. Schwartz PJ, Bonazzi 0, Locati E, Napolitano C, Sala S. Pathogenesis and therapy of the idiopathic long QT syndrome. Ann N Y Acad Sci 1992:644:112-141
46. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995:122:701-714
47. Zhou JT, Zheng LR, Liu WY. Role of early afterdepolarization in familial long QTU syndrome and torsade de pointes. Pacing Clin Electrophysiol 1992:15:2164-2168
48. Ben-David J, Zipes DP. Torsades de pointes and proarrhythmia. Lancet 1993:341:1578-1582
49. Viskin S, Alia SR, Barren HV, Heller K, Saxon L, Kitzis I, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996:28:1262-1268
50. Roden DM. A practical approach to torsade de pointes. Clin Cardiol 1997;20:285-290
51. Kass RS, Davies MP. The roles of ion channels in an inherited heart disease: molecular genetics of the long QT syndrome. Cardiovasc Res 1996;32:443-454
52. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM (SADS Foundation Task Force on LQTS). Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions. Circulation 1996:94:1996-2012
53. Towbin JA. New revelations about the long-QT syndrome. N Engl J Med 1995:333:384-385
54. Vincent GM. Heterogeneity in the inherited long QT syndrome. J Cardiovasc Electrophysiol 1995 ;6:137-146
55. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991:252:704-706
56. Curran M, Atkinson D, Timothy K, Vincent GM, Moss AJ, Leppert M, et al. Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest 1993;92:799-803
57. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. A/at Genet 1996:12:17-23
58. Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY, Blanar MA. KvLQTl, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc A/at/ Acad Sci U S A 1997:94:40174021
59. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. KvLQTl and IsK (minK) proteins associate to form the lKs cardiac potassium current. Nature 1996;384:78-80
60. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, et al. Coassembly of KuLQTl and minK (IsK) proteins to form cardiac IKS potassium channel. Nature 1996:384:80-83
61. Tanaka T, Nagal R, Tomoike H, Takata S, Yano K, Yabuta K, et al. Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. Circulation 1997:95:565-567
62. Russell MW, Dick M II, Collins FS, Brody LC. KVLQT1 mutations in three families with familial or sporadic long QT syndrome. Hum Mol Genet 1996;5:1319-1324
63. Shalaby FY, Levesque PC, Yang WP, Little WA, Conder ML, JenkinsWest T, et al. Dominant-negative KvLQTl mutations underlie the LQT1 form of long QT syndrome. Circulation 1997;96:1733-1736
64. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. A/at Genet 1994;8:141-147
65. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995:80:795-803
66. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995:269:92-95
67. Kiehn J, Lacerda AE, Wible B, Brown AM. Molecular physiology and pharmacology of HERG: single-channel currents and block by dofetilide. Circulation 1996:94:2572-2579
68. Smith PL, Baukrowitz T, Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature 1996:379:833-836
69. Miller C. The inconstancy of the human heart. Nature 1996:379:767-768
70. Benson DW, MacRae CA, Vesely MR, Walsh EP, Scidman JG, Scidman CE, et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation 1996:93:1791-1795
71. Satler CA, Walsh EP, Vesely MR, Plummer MH, Ginsburg GS, Jacob HJ. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes the long QT syndrome. Am J Med Genet 1996:65:27-35
72. Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc A/at/ Acad Sci USA 1996;93:2208-2212
73. Li X, Xu J, Li M. The human deltal261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression. J Biol Chem 1997:272:705-708
74. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995:80:805-811
75. Hudson AJ, Ebers GC, Bulman DE. The skeletal muscle sodium and chloride channel diseases. Brain 1995:118:547-563
76. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995:376:683685
77. Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwarte PJ, Brown AM, et al. Multiple mechanisms of Na+ channel-linked long-QT syndrome. Circ Res 1996;78:916-924
78. Wang DW, Yazawa K, George AL Jr, Bennett PB. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci U S A 1996:93:13200-13205
79. Schott JJ, Charpentier F, Peltier S, Foley P, Drouin E, Bouhour JB, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genêt 1995:57:1114-1122
80. Onozuka M, Furuichi H, Imai S, Fukami Y. Evidence that Ça2/ calmodulin-dependent protein phosphorylation is involved in the opening process of potassium channels in identified snail neurons. Neurosci Lett 1991;124:35-38
81. Romey G, Attali B, Chouabe C, Abitbol I, Guillemare E, Barhanin J, et al. Molecular mechanism and functional significance of the MinK control of the KvLQTl channel activity. J Biol Chem 1997; 272:16713-16716
82. Marks ML, Whisler SL, Clericuzio C, Keating M. A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol 1995:25:59-64
83. Marks ML, Trippel DL, Keating MT. Long QT syndrome associated with syndactyly identified in females. Am J Cardiol 1995:76:744745
84. Eldar M, Griffin JC, Van Hare GF, Withered C, Bhandari A, Benditt D, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992:20:830-837
85. Ouriel K, Moss AJ. Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg 1995:3:475-478
86. Epstein AE, Rosner MJ, Hageman GR, Baker JH II, Plumb VJ, Kay GN. Posterior left thoracic cardiac sympathectomy by surgical division of the sympathetic chain: an alternative approach to treatment of the long QT syndrome. Pacing Clin Electrophysiol 1996:19:10951104
87. Schwartz PJ. Long Q-T syndrome. In: Horowitz LN, editor. Current Management of Arrhythmias. Philadelphia: BC Decker; 1991. pp 194-198
88. Shimizu W, Ohe T, Kurita T, Kawade M, Arakaki Y, Aihara N, et al. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995;26:1299-1309
89. Schwartz PJ. The idiopathic long QT syndrome: the need for a prospective registry. Eur Heart J 1983;4:529-531
90. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 1995:92:3381-3386
91. Shen CT, Wu YC, Yu SS, Wang NK. Multi-undulant T-U-wave, sinus bradycardia and long QT syndrome: a possible phenotype of mutant genes controlling the inward potassium rectifiers. Acta Paediatr Sin 1997:38:267-275
92. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995:92:2929-2934
93. Dausse E, Berthet M, Denjoy I, André-Fouet X, Cruaud C, Bennaceur M, et al. A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol 1996:28:1609-1615
94. Priori SG, Napolitano C, Cantu F, Brown AM, Schwarte PJ. Differential response to Na channel blockade, -adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res 1996:78:10091015
95. An RH, Bangalore R, Rosero SZ, Kass RS. Lidocaine block of LQT-3 mutant human Na+ channels. Circ Res 1996;79:103-108
96. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the lKr potassium channel. Cell 1995:81:299-307
97. Compton SJ, Lux RL, Ramsey MR, Strelich KR, Sanguinetti MC, Green LS, et al. Genetically defined therapy of inherited long-QT syndrome: correction of abnormal repolarization by potassium. Circulation 1996:94:1018-1022
98. Carlsson L, Abrahamsson C, Drews L, Düker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation 1992:85:14911500
99. Sato T, Hata Y, Yamamoto M, Morita H, Mizuo K, Yamanari H, et al. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome. J Cardiovasc Electrophysiol 1995:6:279-282
100. Ono K, Noma A. Autonomie regulation of cardiac chloride current. Jpn J Physiol 1994;44(Suppl 2):S193-S198
101. Ackerman MJ, Clapham DE. Cardiac chloride channels. Trends Cardiovasc Med 1993;3:23-28
102. Gadsby DC, Nagel G, Hwang T-C. The CFTR chloride channel of mammalian heart. Annu Rev Physiol 1995:57:387-416
103. Hume JR, Hart P, Levesque PC, Collier ML, Geary Y, Warth J, et al. Molecular physiology of CFTR CI- channels in heart. Jpn J Physiol 1994;44(Suppl 2):S177-S182
104. Snyders DJ, Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 1996:49:949-955
105. Crumb WJ Jr, Wible B, Arnold DJ, Payne JP, Brown AM. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 1995:47:181-190
106. Doggrell S, Hoey A, Brown L. Ion channel modulators as potential positive inotropic compound for treatment of heart failure. Clin Exp Pharmacol Physiol 1994;21:833-843